Cannabis
Dronabinol similar in safety and efficacy as diphenhydramine for neuropathic pain relief
Am J Phys Med Rehabil. 2010 Oct;89(10):840-8. doi: 10.1097/PHM.0b013e3181f1c4ec9 patients with spinal cord injury and experiencing chronic neuropathic pain were randomly assigned to treatment with either dronabinol or diphenhydramine for 56 days, and then crossed over to the other medication for 56 days after a 7-day washout period. Patient-reported pain intensity and the incidence of side effects were assessed at the beginning and the end of each medication phase. The results demonstrated that there was no significant difference in the efficacy and safety profiles between the two medications.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
